Share on LinkedInShare on LinkedIn

ARTICLE · 04 JUNE 2026

Clinically Proven? Prove It.

Lewis Silkin
Lewis Silkin
Contributor
Lewis Silkin

Lewis Silkin

Joint managing partners: Jo Farmer, Richard Miskella International offices: Dublin, Hong Kong...

View firm profile
Explore more from Lewis Silkin

The Advertising Standards Authority has tightened its enforcement on "clinically proven" beauty claims, requiring brands to substantiate such assertions with rigorous clinical trials rather than consumer use tests.

United KingdomConsumer Protection

The phrase "clinically proven" is one of the most powerful claims in a beauty marketer's 'Arsenal'*. It sounds scientific, authoritative, and reassuring. But in a ruling published in April 2026, the Advertising Standards Authority made clear that brands invoking those words must back them up with robust evidence. Claims which are capable of objective substantiation must be substantiated with objective, not subjective evidence. Two further rulings published in April and May 2026 indicate a consistent approach by the ASA.

In the health and beauty sector 'robust evidence' means experimental human studies, i.e. 'clinical trials'. These are the gold standard for objective substantiation. They comprise rigorously controlled trials in humans where an intervention group uses the product, and a control group uses a placebo. They are typically double-blind, where neither the subjects nor the researchers know who is in which group, minimizing bias. In recent years, however, we've seen a trend

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from